Tower Research Capital LLC (Trc) Intellipharmaceutics International Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$0.17 - $0.39 $17 - $39
-100 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$2.4 - $5.3 $240 - $530
100 New
100 $0

About Intellipharmaceutics International Inc.

IPCIF Quotes by TradingView
  • Ticker IPCIF
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,092,700
  • Market Cap $4.96M
  • Description
  • Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in...
More about IPCIF
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email